POTASSIUM PHOSPHATES
Active substance: MONOBASIC POTASSIUM PHOSPHATE, DIBASIC POTASSIUM PHOSPHATE
INJECTION, SOLUTION, CONCENTRATE · MONOBASIC POTASSIUM PHOSPHATE 224 mg/mL, DIBASIC POTASSIUM PHOSPHATE 236 mg/mL
United StatesActive
Marketing holder: GLENMARK PHARMACEUTICALS INC., USA
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- MONOBASIC POTASSIUM PHOSPHATE · 224 mg/mL
- DIBASIC POTASSIUM PHOSPHATE · 236 mg/mL
Registration
- Registration number
- 68462-787
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 68462-787 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68462-787 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68462-787 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 68462-787 · Verified 2026-10-09 · open in source